The Role of Dopamine Replacement on the Behavioural Phenotype of Parkinson’s Disease

The Role of Dopamine Replacement on the Behavioural Phenotype of Parkinson’s Disease

Bibliographic Details
Main Authors:	Hajar Alobaidi, Hardev Pall
Format:	Article
Language:	English
Published:	Hindawi Limited 2013-01-01
Series:	Behavioural Neurology
Online Access:	http://dx.doi.org/10.3233/BEN-2012-120265

Similar Items

The degeneration and replacement of dopamine cells in Parkinson’s disease: the role of aging.
by: Manuel eRodriguez, et al.
Published: (2014-08-01)

Differential effects of Parkinson's disease and dopamine replacement on memory encoding and retrieval.
by: Alex A MacDonald, et al.
Published: (2013-01-01)

Dopamine replacement therapy reduces beta band burst duration in Parkinson’s disease
by: Mecconi, Alessandro
Published: (2017)

Decisions, Decisions: The Neurobiology of the effects of Dopamine Replacement Therapy on Decision-Making in Parkinson’s Disease
by: Julie Lee
Published: (2015-05-01)

Gambling Disorder during Dopamine Replacement Treatment in Parkinson’s Disease: A Comprehensive Review
by: Domenico Pirritano, et al.
Published: (2014-01-01)

Nonmotor outcomes in Parkinson’s disease: is deep brain stimulation better than dopamine replacement therapy?
by: Rupam Borgohain, et al.
Published: (2012-01-01)

The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease
by: Lena F. Burbulla, et al.
Published: (2019-12-01)

Dopamine dysregulation syndrome in Parkinson’s disease
by: A V Nikitina, et al.
Published: (2013-03-01)

A Role for Dopamine-Mediated Learning in the Pathophysiology and Treatment of Parkinson’s Disease
by: Jeff A. Beeler, et al.
Published: (2012-12-01)

A Role for Dopamine-Mediated Learning in the Pathophysiology and Treatment of Parkinson’s Disease
by: Jeff A. Beeler, et al.
Published: (2014-07-01)

Impaired dopamine metabolism in Parkinson’s disease pathogenesis
by: Anna Masato, et al.
Published: (2019-08-01)

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
by: Fatma Haddad, et al.
Published: (2017-12-01)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
by: Heinz Reichmann
Published: (2009-05-01)

Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease
by: Ariane Park, et al.
Published: (2011-01-01)

Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
by: Alexandre Iarkov, et al.
Published: (2020-01-01)

The Role Of Dopamine In Risk Taking: A Specific Look At Parkinson’s Disease And Gambling.
by: Crystal A Clark, et al.
Published: (2014-05-01)

Parkinson's disease: the role of dopamine transporter neuroimaging in clinically unclear cases (Abstract)
by: Andre Carvalho Felicio
Published: (2012-05-01)

Effects of dopamine on reinforcement learning and consolidation in Parkinson’s disease
by: John P Grogan, et al.
Published: (2017-07-01)

Schizotypy in Parkinson’s disease predicts dopamine-associated psychosis
by: Carina R. Oehrn, et al.
Published: (2021-01-01)

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
by: Danielle E Mor, et al.
Published: (2018-03-01)

DOPAMINE AND THE BIOLOGY OF CREATIVITY: LESSONS FROM PARKINSON’S DISEASE
by: Eugénie eLhommée, et al.
Published: (2014-04-01)

Effects of dopamine on sensitivity to social bias in Parkinson's disease.
by: Atbin Djamshidian, et al.
Published: (2012-01-01)

Habitual behavior and dopamine cell vulnerability in Parkinson disease
by: Ledia eF. Hernandez, et al.
Published: (2015-11-01)

The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease
by: Marina Romanovna Nodel
Published: (2013-11-01)

To dopamine and beyond, a review of the mechanisms of Parkinson's disease
by: Chester, Andrew
Published: (2018)

The role of genetic risk factors on the phenotype of Parkinson's Disease
by: Clark, Graeme Richard
Published: (2008)

Reactive dopamine metabolites and neurotoxicity : the role of GAPDH and pesticide exposure in Parkinson's disease pathology
by: Vanle, Brigitte Chantal
Published: (2016)

Physiological and Functional Basis of Dopamine Receptors and Their Role in Neurogenesis: Possible Implication for Parkinson’s disease
by: Akanksha Mishra, et al.
Published: (2018-05-01)

Sensory attenuation in Parkinson’s disease is related to disease severity and dopamine dose
by: Noham Wolpe, et al.
Published: (2018-10-01)

Deep Phenotyping of Parkinson's Disease
by: Dorsey, E. Ray, et al.
Published: (2021)

Beyond Dopamine: GABA, Glutamate, and the Axial Symptoms of Parkinson Disease
by: Ruth L. O'Gorman Tuura, et al.
Published: (2018-09-01)

Dopamine and Acetylcholine, a Circuit Point of View in Parkinson’s Disease
by: Giorgio Rizzi, et al.
Published: (2017-12-01)

Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
by: Lijuan Hou, et al.
Published: (2017-11-01)

Parkinson’s disease and dopamine transporter neuroimaging: a critical review
by: Ming Chi Shih, et al.

The Influence of Dopamine on Automatic and Controlled Semantic Activation in Parkinson's Disease
by: Wendy L. Arnott, et al.
Published: (2011-01-01)

Dopamine Does Not Appear to Affect Mental Rotation in Parkinson’s Disease
by: Gregory P. Crucian, et al.
Published: (2014-10-01)

Habitual Behavior and Dopamine Cell Vulnerability in Parkinson´s Disease
by: Ledia eF. Hernandez, et al.
Published: (2015-08-01)

Gait Initiation in Parkinson's Disease: The Interplay of Dopamine and Postural Control
by: Brandt, Gregor A.
Published: (2020)

Imaging the dopamine transporter in dementia and Parkinson's disease using SPECT
by: Colloby, Sean J.
Published: (2005)

Serotonin- and Dopamine-mediated Neurotransmission in the Pathophysiology and Treatment of Parkinson’s Disease
by: Huot, Philippe
Published: (2012)